Evaluation of the potential genotoxicity of chromium picolinate in mammalian cells in vivo and in vitro

Food and Chemical Toxicology

Volumn 45, Issue 7, 2007, Pages 1097-1106

  Andersson, Maria A ^a   Petersson Grawé, Kierstin V ^b   Karlsson, Oskar M ^a   Abramsson Zetterberg, Lilianne A G ^b   Hellman, Björn E ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b NATIONAL FOOD ADMINISTRATION   (Sweden)

Author keywords

Chromium picolinate; Comet assay; Flow cytometric micronucleus test; Mouse and human lymphocytes; Mouse bone marrow cells; Mouse hepatocytes; Mouse lymphoma cells

Indexed keywords

CHROMIUM PICOLINATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; DRUG DOSE COMPARISON; DRUG EFFECT; ERYTHROCYTE; GENOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA L 5178 Y; LIVER CELL; LYMPHOCYTE CULTURE; LYMPHOMA CELL LINE; MALE; MAMMAL CELL; MICRONUCLEUS; MOUSE; NONHUMAN; SINGLE DRUG DOSE; TOXICITY TESTING;

ANIMALS; CELL COUNT; CELL LINE, TUMOR; COMET ASSAY; DIETARY SUPPLEMENTS; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROCYTES; HEPATOCYTES; HUMANS; INJECTIONS, INTRAPERITONEAL; LEUKEMIA L5178; LYMPHOCYTES; MALE; MICE; MICE, INBRED CBA; MICRONUCLEI, CHROMOSOME-DEFECTIVE; MICRONUCLEUS TESTS; MUTAGENICITY TESTS; MUTAGENS; PICOLINIC ACIDS;

MAMMALIA; MUS;

EID: 34247149297     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2006.11.008     Document Type: Article

References (61)

1. 137Cs at very low dose rates. Int. J. Rad. Biol. 67 (1995) 29-36
2. Abramsson-Zetterberg L., Zetterberg G., and Grawé J. The time course of micronucleated polychromatic erythrocytes in mouse bone marrow and peripheral blood. Mutat. Res. 350 (1996) 349-358
3. Althuis M.D., Jordan N.E., Ludington E.A., and Wittes J.T. Glucose and insulin responses to dietary chromium supplements: a meta-analysis. Am. J. Clin. Nutr. 76 (2002) 148-155
4. Anderson R.A. Nutritional role of chromium. Sci. Total Environ. 17 (1981) 13-29
5. Anderson D., Yu T.-W., Phillips B.J., and Schmezer P. The effect of various antioxidants and other modifying agents on oxygen-radical-generated DNA damage in human lymphocytes in the Comet assay. Mutat. Res. 307 (1994) 261-271
6. Anderson R.A., Bryden N.A., Polansky M.M., and Gautschi K. Dietary chromium effects on tissue chromium concentrations and chromium absorption in rats. J. Trace Elem. Exp. Med. 9 (1996) 11-25
7. Anderson R.A., Cheng N., Bryden N.A., Polansky M.M., Cheng N., Chi J., and Feng J. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes 46 (1997) 1786-1791
8. Anderson R.A., Bryden N.A., and Polansky M.M. Lack of toxicity of chromium chloride and chromium picolinate in rats. J. Am. Coll. Nutr. 16 (1997) 273-279
9. Andersson M.A., and Hellman B.E. Different roles of Fpg and Endo III on catechol-induced DNA damage in extended-term cultures of human lymphocytes and L5178Y mouse lymphoma cells. Toxicol. In Vitro 19 (2005) 779-786
10. Andersson M., Agurell E., Vaghef H., Bolcsfoldi G., and Hellman B. Extended-term cultures of human T-lymphocytes and the comet assay: a useful combination when testing for genotoxicity in vitro?. Mutat. Res. 540 (2003) 43-55
11. Arslan P., Beltrame M., and Tomasi A. Intracellular chromium reduction. Biochim. Biophys. Acta 931 (1987) 10-15
12. Bagchi D., Bagchi M., Balmoori J., Ye X., and Stohs S.J. Comparative induction of oxidative stress in cultured J774A.1 macrophage cells by chromium by chromium picolinate and chromium nicotinate. Res. Commun. Mol. Pathol. 97 (1997) 335-346
13. Cerulli J., Grabe D.W., Gauthier I., Malone M., and McGoldrick M.D. Chromium picolinate toxicity. Ann. Pharmacother. 32 (1998) 428-431
14. Cole R.J., Taylor N., Cole J., and Arlett C.F. Short term test for transplacentally active carcinogens. I. Micronucleus formation in fetal and maternal mouse erythroblasts. Mutat. Res. 80 (1981) 141-157
15. Davidson J.R.T., Abraham K., Connor K.M., and McLeod M.N. Effectiveness of chromium in atypical depression: a placebo-controlled trial. Biol. Psychiat. 53 (2003) 261-264
16. De Flora S., Bagnasco M., Serra D., and Zanacchi P. Genotoxicity of chromium compounds. A review. Mutat. Res. 238 (1990) 99-172
17. Esber H., and Moreno V. Evaluation of chromium picolinate in the rat in vivo chromosomal aberration assay. Environ. Mol. Mutagen. 29 suppl. 28 (1997) 15
18. Fishbein L. Sources, transport and alterations of metal compounds: an overview. I. Arsenic, beryllium, cadmium, chromium and nickel. Environ. Health Persp. 40 (1981) 43-64
19. Gammelgaard B., Jensen K., and Steffansen B. In vitro metabolism and permeation studies in rat jeujunum: organic chromium compared to inorganic chromium. J. Trace Elem. Med. Biol. 13 (1999) 82-88
20. Gosh D., Bhattacharya B., Mukherjee B., Manna B., Sinha M., Chowdhury J., and Chowdhury S. Role of chromium supplementation in Indians with type 2 diabetes mellitus. J. Nutr. Biochem. 13 (2002) 690-697
21. Grawé J., Zetterberg G., and Amneus H. Flow-cytometric enumeration of micronucleated erythrocytes in mouse peripheral blood. Cytometry 13 (1992) 750-758
22. Grawé J., Zetterberg G., and Amneus H. Effects of extended low dose-rate exposure to 137 Cs detected by flow cytometric enumeration of micronucleated erythrocytes in mouse peripheral blood. Int. J. Rad. Biol. 63 (1993) 339-347
23. Hartmann A., and Speit G. The contribution of cytotoxicity to DNA-effects in the single cell gel test (comet assay). Toxicol. Lett. 90 (1997) 183-188
24. Hayashi M., Norppa H., Sofuni T., and Ishidate Jr. M. Flow cytometric micronucleus test with mouse peripheral erythrocytes. Mutagenesis 7 (1992) 257-264
25. Hellman B., Vaghef H., and Boström B. The concepts of tail moment and tail inertia in the single cell gel electrophoresis assay. Mutat. Res. 336 (1995) 123-131
26. Hepburn D.D., and Vincent J. In vivo distribution of chromium from chromium picolinate in rats and implications for the safety of the dietary supplement. Chem. Res. Toxicol. 15 (2002) 93-100
27. Hepburn D.D., Xiao J., Bindom S., Vincent J.B., and O'Donnell J. Nutritional supplement chromium picolinate causes sterility and lethal mutations in Drosophila melanogaster. Proc. Natl. Acad. Sci. USA 100 (2003) 3766-3771
28. Hepburn D., Burney M., Wosky S., and Vincent J. The nutritional supplement chromium picolinate generates oxidative DNA damage and peroxidized lipids in vivo. Polyhedron 22 (2003) 455-463
29. Huszonek J. Over-the-counter chromium picolinate. Am. J. Psychiat. 150 (1993) 1560-1561
30. IARC. Chromium, nickel and welding. IARC Monographs on the Evaluation of Carcinogenic Risk to Humans vol. 49 (1990), International Agency for Research on Cancer, Lyon
31. Kato I., Vogelman J.H., Dilman V., Karkoszka J., Frenkel K., Durr N.P., Orentreich N., and Toniolo P. Effect of supplementation with chromium picolinate on antibody titers to 5-hydroxymethyl uraccil. Eur. J. Epidemiol. 14 (1998) 621-626
32. Lamson D.W., and Plaza S.M. The safe and efficacy of high-dose chromium. Altern. Med. Rev. 7 (2002) 218-235
33. MacGregor J.T., Wehr C.M., and Gould D.H. Clastogen-induced micronuclei in peripheral blood erythrocytes: the basis of an improved micronucleus test. Environ. Mutagen. 2 (1980) 509-514
34. Martin W.R., and Fuller R.E. Suspected chromium picolinate-induced rhabdomyolysis. Pharmacotherapy 18 (1998) 860-862
35. McCarty M.F. Chromium (III) picolinate. FASEB J. 10 (1996) 365-366
36. Michenfelder H.J., Thompson J., and Shepherd M. Over-the-counter chromium and renal failure. Ann. Intern. Med. 127 (1997) 655
37. Mirasol F. Chromium picolinate market sees robust growth and high demand. Chem. Market Reporter 257 (2000) 26
38. Miyamae Y., Yamamoto M., Sasaki Y.F., Kobayashi H., Igarashi-Soga M., Shimoi K., and Hayashi M. Evaluation of a tissue homogenization technique that isolates nuclei for the in vivo single cell gel electrophoresis (comet) assay: a collaborative study by five laboratories. Mutat. Res. 418 (1998) 131-140
39. National Toxicology Program (NTP), 2004. NTP: Testing status: Chromium picolinate M980072. Available from: .
40. O'Brien T.J., Ceryak S., and Patierno S.R. Complexities of chromium carcinogenesis: role of cellular response, repair and recovery mechanisms. Mutat. Res. 533 (2003) 3-36
41. O'Donovan M.R.O., Freemantle M.R., Hull G., Bell D.A., Arlett C.F., and Cole J. Extended-term cultures of human T-lymphocytes: a practical alternative to primary human lymphocytes for use in genotoxicity testing. Mutagenesis 10 (1995) 189-201
42. Pittler M.H., and Ernst E. Dietary supplements for body-weight reduction: a systematic review. Am. J. Clin. Nutr. 79 (2004) 529-536
43. Pittler M.H., Stevinson C., and Ernst E. Chromium picolinate for reducing body weight: meta-analysis of randomized trials. Int. J. Obesity 27 (2003) 522-529
44. Rasco J.F., Hood R.D., Karatheodoris L., McAliley L.C., Noel J.R., Swain K.D., Hestor D.L., Zander C.V., Hepburn D.D., and Vincent J.B. Developmental toxicity of chromium(III) picolinate in mice. Birth Defects Res. A 67 (2003) 357
45. Repine J.E., Pfenninger O.W., Talmage D.W., Berger E.M., and Pettijohn D.E. Dimethyl sulfoxide prevents DNA nicking mediated by ionizing radiation or iron/hydrogen peroxide-generated hydroxyl radical. Proc. Natl. Acad. Sci. USA 78 (1981) 1001-1003
46. 1 mice following subchronic administration of chromium picolinate monohydrate. Food Chem. Toxicol. 43 (2005) 21-29
47. Sasaki Y.F., Izumiyama F., Nishidate E., Matsusaka N., and Tsuda S. Detection of rodent liver carcinogen genotoxicity by the alkaline single-cell gel electrophoresis (Comet) assay in multiple mouse organs (liver, lung, spleen, kidney, and bone marrow). Mutat. Res. 391 (1997) 201-214
48. Singh N.P., McCoy M.T., Tice R.R., and Schneider E.L. A simple technique for quantification of low levels of DNA-damage in individual cells. Exp. Cell Res. 175 (1988) 184-191
49. Snow E.T. Metal carcinogenesis: mechanistic implications. Pharmacol. Therapeut. 53 (1992) 31-65
50. Speetjens J.K., Collins R.A., Vincent J.B., and Woski S.A. The nutritional supplement chromium (III) tris(picolinate) cleaves DNA. Chem. Res. Toxicol. 12 (1999) 483-487
51. Stearns D. Is chromium an essential trace metal?. Biofactors 11 (2000) 149-162
52. Stearns D.M., Wise J.P., Patierna S.R., and Wetterhahn K.E. Chromium(III) picolinate produces chromosome damage in Chinese hamster ovary cells. FASEB J. 9 (1995) 1643-1648
53. Stearns D.M., Kennedy L.J., Courtney K.D., Giangrande P.H., Phieffer L.S., and Wetterhahn K.E. Reduction of chromium(VI) by ascorbate leads to chromium-DNA binding and DNA strand breaks in vitro. Biochemistry 34 (1995) 910-919
54. Stearns D.M., Belbruno J.J., and Wetterhahn K.E. A prediction of chromium (III) accumulation in humans from chromium dietary supplements. FASEB J. 9 (1995) 1650-1657
55. Stearns D.M., Silverira S.M., Wolf K.K., and Luke A.M. Chromium(III) tris(picolinate) is mutagenic at the hypxantine(guanine)phosphoribosyltransferase locus in Chinese hamster ovary cells. Mutat. Res. 513 (2002) 135-142
56. Vaghef H., and Hellman B. Demonstration of chlorobenzene-induced DNA damage in mouse lymphocytes using the single cell gel electrophoresis assay. Toxicology 96 (1995) 19-28
57. Vaghef H., Wisén A.-C., and Hellman B. Demonstration of bens(a)pyrene-induced DNA-damage in mice by alkaline single cell gel electrophoresis: evidence for strand breaks in liver. Pharmacol. Toxicol. 78 (1996) 37-43
58. Vincent J.B. The bioinorganic chemistry of chromium (III). Polyhedron 20 (2001) 1-26
59. Vincent J.B. The potential value and toxicity of chromium picolinate as a nutritional supplement, weight loss agent and muscle developmental agent. Sports Med. 33 (2003) 213-230
60. Wasser W.G., Feldman N.S., and D'Agati V.D. Chronic renal failure after ingestion of over-the-counter chromium picolinate. Ann. Intern. Med. 126 (1997) 410
61. Whittaker P., San R.H.C., Clarke J.J., Seifried H.E., and Dunkel V.C. Mutagenicity of chromium picolinate and its components in Salmonella typhimurium and L5178Y mouse lymphoma cells. Food Chem. Toxicol. 43 (2005) 1619-1625